IceCure Medical (ICCM) Net Margin (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Net Margin data on file, last reported at 466.19% in Q1 2026.

• On a quarterly basis, Net Margin fell 2871.0% year-over-year to 466.19% in Q1 2026; TTM through Mar 2026 was 440.76%, a 70137.0% increase from a year earlier, with the FY2025 full-year figure at 351.76%, up 36826.0% from the prior year.
• Net Margin for Q1 2026 stood at 466.19%, up from 331.74% in the prior quarter.
• Over the last five years, Net Margin for ICCM reached as high as 1223.24% in Q3 2023 and fell as low as 4989.99% in Q4 2022.
• Historically, Net Margin has averaged 183.49% across 5 years, with a median of 485.73% in 2024.
• Across the five-year window, Net Margin tumbled 278428 bps in 2022 and jumped 254294 bps in 2025, its largest moves.
• Year by year, Net Margin stood at 4989.99% in 2022, then increased by 25 bps to 3737.85% in 2023, then surged by 41 bps to 2211.2% in 2024, then surged by 115 bps to 331.74% in 2025, then jumped by 41 bps to 466.19% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 466.19% in Q1 2026, 331.74% in Q4 2025, and 454.0% in Q3 2025.